1-5 of 5
Henrikki Almusa
Close
Sort by
Journal Articles

Distinct Genetic and Fragmentomic Signatures of Plasma Ctdna Synergize and Resolve Clinical Challenges in Patients with Large B-Cell Lymphoma

Leo Meriranta, Maare Arffman, Judit Mészáros Jørgensen, Harald Holte, Kristina Drott, Henrikki Almusa, Emma Saarinen, Sari Hannula, Marja-Liisa Karjalainen-Lindsberg, Klaus Beiske, Mette Ølgod Pedersen, Øystein Fluge, Peter de Nully Brown, Sirkku Jyrkkiö, Sirpa Leppä
Journal: Blood
Blood (2023) 142 (Supplement 1): 1625.
https://doi.org/10.1182/blood-2023-188493
Published: 2023
Journal Articles

Analysis of Clonal Evolution in Chemorefractory Acute Myeloid Leukemia from Diagnosis to Relapse

Naga Poojitha Ojamies, MSc, Mika Kontro, MD, Maija Wolf, PhD, Henrik Edgren, PhD, Pekka Ellonen, MSc, Sonja Lagström, MSc, Tiina Hannunen, MSc, Tea Pemovska, MSc, Henrikki Almusa, MSc, Maija Lepistö, MSc, Caroline A Heckman, PhD, Krister Wennerberg, PhD, Kimmo Porkka, MD PhD, Olli Kallioniemi, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1022.
https://doi.org/10.1182/blood.V124.21.1022.1022
Published: 2014
Journal Articles

Identification Of AML Subtype-Selective Drugs By Functional Ex Vivo Drug Sensitivity and Resistance Testing and Genomic Profiling

Tea Pemovska, MSc, Mika Kontro, MD, Bhagwan Yadav, MSc, Henrik Edgren, PhD, Samuli Eldfors, MSc, Agnieszka Szwajda, MSc, Henrikki Almusa, MSc, Maxim Bespalov, PhD, Pekka Ellonen, MSc, Erkki Elonen, MD, PhD, Bjorn T Gjertsen, MD PhD, Riikka Karjalainen, MSc, Evgeny Kulesskiy, MSc, Sonja Lagström, MSc, Anna Lehto, MSc, Maija Lepistö, MSc, Tuija Lundan, PhD, Muntasir Mamun Majumder, MSc, Jesus Maria Lopez Marti, PhD, Pirkko Mattila, PhD, Astrid Murumägi, PhD, Satu Mustjoki, MD, PhD, Aino Palva, MSc, Alun Parsons, MSc, Tero Pirttinen, MD, Maria E Rämet, MD, Minna Suvela, BSc, Laura Turunen, MSc, Imre Västrik, PhD, Maija Wolf, PhD, Jonathan Knowles, PhD, Tero Aittokallio, PhD, Caroline A Heckman, PhD, Kimmo Porkka, MD, PhD, Olli Kallioniemi, MD, PhD, Krister Wennerberg, PhD
Journal: Blood
Blood (2013) 122 (21): 482.
https://doi.org/10.1182/blood.V122.21.482.482
Published: 2013
Journal Articles

High-Throughput Ex Vivo Drug Sensitivity and Resistance Testing (DSRT) Integrated with Deep Genomic and Molecular Profiling Reveal New Therapy Options with Targeted Drugs in Subgroups of Relapsed Chemorefractory AML

Caroline A Heckman, PhD, Mika Kontro, MD, Tea Pemovska, MSc, Samuli Eldfors, MSc, Henrik Edgren, MSc, Evgeny Kulesskiy, MSc, Muntasir Mamun Majumder, MSc, Riikka Karjalainen, MSc, Bhagwan Yadav, MSc, Agnieszka Szwajda, MSc, Naga Poojitha Kota Venkata, MSc, Astrid Murumägi, PhD, Disha Malani, MSc, Alun Parsons, MSc, Petteri Hintsanen, PhD, Henrikki Almusa, MSc, Jesús María López Martí, PhD, Pekka Ellonen, MSc, Pirkko Mattila, PhD, Maija Lepistö, MSc, Sonja Lagström, MSc, Minna Suvela, BSc, Satu Mustjoki, MD, PhD, Janna Saarela, MD, PhD, Tero Aittokallio, PhD, Olli Kallioniemi, MD, PhD, Krister Wennerberg, PhD, Kimmo Porkka, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 288.
https://doi.org/10.1182/blood.V120.21.288.288
Published: 2012
Journal Articles

Recurrent Missense Mutations in the STAT3 Gene in LGL Leukemia Provide Insights to Pathogenetic Mechanisms and Suggest Potential Diagnostic and Therapeutic Applications

Hanna Koskela, MD, Samuli Eldfors, MSc, Henrikki Almusa, MSc, Emma Andersson, Pekka Ellonen, BSc, Henrik Edgren, MSc, Pirjo Koistinen, MD, PhD, Taru Kuittinen, MD, PhD, Kati Penttinen, Jonathan Knowles, PhD, Janna Saarela, MD, PhD, Olli Kallioniemi, MD, PhD, Krister Wennerberg, PhD, Kimmo Porkka, MD, PhD, Caroline Heckman, PhD, Satu Mustjoki, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 936.
https://doi.org/10.1182/blood.V118.21.936.936
Published: 2011